ABVAX | VIVAX | ABVAX / VIVAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 24 years | 32 years | - |
Gain YTD | 4.723 | 4.148 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 452M | 193B | 0% |
Annual Yield % from dividends | 1.03 | 2.25 | 46% |
Returns for 1 year | 4.86 | 13.43 | 36% |
Returns for 3 years | 7.96 | 23.92 | 33% |
Returns for 5 years | 22.00 | 47.22 | 47% |
Returns for 10 years | 31.64 | 105.56 | 30% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VCIGX | 13.08 | -0.10 | -0.76% |
VALIC Company I Dividend Value | |||
FTADX | 50.28 | -0.48 | -0.95% |
Fidelity Advisor International Discv M | |||
BCVCX | 30.27 | -0.36 | -1.18% |
Sterling Capital Behav Lg Cp Val Eq C | |||
SRUAX | 14.04 | -0.27 | -1.89% |
Meeder Spectrum Adviser | |||
BRMAX | 15.00 | -0.33 | -2.15% |
iShares Russell Mid-Cap Index Inv A |